We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




PACS Company Honored by Award

By HospiMedica staff writers
Posted on 09 Nov 2005
Heartlab (Westerly, RI, USA), an Agfa (Mortsel, Belgium) company, recently announced a 2005 Business Development Leadership Award from Frost & Sullivan (Palo Alto, CA, USA), the international growth consultancy company. More...


The award recognizes Heartlab's ability to perceive and meet consumer needs by successfully developing and introducing products and services and by identifying new market segments to expand the existing customer base.

"In the intensely competitive U.S. cardiology PACS [picture archiving and communication systems] environment, Heartlab has consistently anticipated and met the needs of the marketplace,” said Katherine Shariq, senior industry analyst at Frost & Sullivan. "Heartlab's rigorous and ongoing analysis of customer needs and its continuous development and adoption of state-of-the-art analytics, network, storage, and IS [information system] integration solutions enables it to meet the future needs of its expanding customer base.”

Moreover, Frost & Sullivan's 2005 survey of the U.S. cardiology (PACS) market showed Heartlab as the third largest provider of cardiology PACS solutions in the United States in 2004. With 17.8% for direct sales and 2.5% for indirect original equipment manufacturer (OEM) sales (through its parent company, Agfa), Heartlab has increased its share of the US$166 million U.S. market by more than 8% from 2002, the last year that Frost & Sullivan surveyed the market.

"As the market continues to evolve, Heartlab has emerged as the only viable modality independent solution provider for Cardiology information systems,” said Robert Petrocelli, Heartlab's CEO.





Related Links:
Agfa
Frost & Sullivan

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.